| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/30/2007 | EP1790639A1 Compound containing basic group and use thereof |
| 05/30/2007 | EP1790637A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 05/30/2007 | EP1790355A1 Propagation agent and propagation method for natural killer cell |
| 05/30/2007 | EP1790340A2 Combination chemotherapy |
| 05/30/2007 | EP1789554A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 05/30/2007 | EP1789093A2 Antibody vaccine conjugates and uses therefor |
| 05/30/2007 | EP1789091A2 Prodrugs containing novel bio-cleavable linkers |
| 05/30/2007 | EP1789086A2 Extended treatment of multiple sclerosis |
| 05/30/2007 | EP1789059A2 Glycosylceramide adjuvant for saccharide antigens |
| 05/30/2007 | EP1789056A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts |
| 05/30/2007 | EP1789054A2 Cannabinoid compositions and methods of use thereof |
| 05/30/2007 | EP1789034A1 Compounds with diphenoyl -structure for the treatment of immune diseases |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1311663B1 Claudin polypeptides |
| 05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 05/30/2007 | EP1257537B1 Therapeutic morpholino-substituted compounds |
| 05/30/2007 | EP1221973B1 CD40 antagonist for treating psoriasis |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | EP0904367B1 Scf analog compositions and methods |
| 05/30/2007 | CN1972914A Non-imidazole heterocyclic compounds as histamine H3-receptor ligands |
| 05/30/2007 | CN1972714A Methods of treating autoimmune and inflammatory diseases |
| 05/30/2007 | CN1972665A Injectable depot compositions and uses thereof |
| 05/30/2007 | CN1970579A High substitution degree carboxymethyl indianbread polysaccharide and its preparation method and uses |
| 05/30/2007 | CN1970549A Chiral benzhydryl piperazine derivatives and its preparation method |
| 05/30/2007 | CN1970538A 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 05/30/2007 | CN1970078A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970077A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970056A Taste improved 'Xin Xue' powder |
| 05/30/2007 | CN1970038A Medicament capable of enhancing immunity, prolonging senility and preventing invasion of pathogen |
| 05/30/2007 | CN1970028A Detoxifying formulation containing astragalus root and greenbrier and preparation process thereof |
| 05/30/2007 | CN1969986A Ganoderma lucidum capsule for improving sleep and immunity, preparation method and use thereof |
| 05/30/2007 | CN1969984A Externally applied medicament for treating acne and allergy |
| 05/30/2007 | CN1969942A Pharmaceutical composition for improving production capacity and immunity of poultry and preparation process thereof |
| 05/30/2007 | CN1969941A Fox immunity enhancer |
| 05/30/2007 | CN1969883A Kidney transplantation exclusion reaction inhibitor |
| 05/30/2007 | CN1969814A Nasal administered preparation of melatonin |
| 05/30/2007 | CN1318589C Method for preparing mammal cell kinetin synthetic inhibitory factor |
| 05/30/2007 | CN1318573C Mycobacterium smegmatis preparation and use thereof |
| 05/30/2007 | CN1318450C Modified/chimeric super-antigens and their use |
| 05/30/2007 | CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 05/30/2007 | CN1318413C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 05/30/2007 | CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 05/30/2007 | CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 05/30/2007 | CN1318103C Medical products comprising a haemocompatible coating, production and use thereof |
| 05/30/2007 | CN1318102C Medical devices containing rapamycin analogs |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
| 05/30/2007 | CN1318084C Neuroprotective peptides |
| 05/30/2007 | CN1318031C Compositions containing benzoxazinone and nucleoside like materials |
| 05/30/2007 | CN1318023C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/29/2007 | US7223867 Preparation of benzosuberonylpiperidine compounds |
| 05/29/2007 | US7223858 Truncated aggrecanase molecules |
| 05/29/2007 | US7223857 Chain-shortened polynucleotide and method for preparation thereof |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
| 05/29/2007 | US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation |
| 05/29/2007 | US7223784 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 05/29/2007 | US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets |
| 05/29/2007 | US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents |
| 05/29/2007 | US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies |
| 05/29/2007 | US7223760 Substituted triazole compounds |
| 05/29/2007 | US7223758 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 05/29/2007 | US7223756 Treatment of autoimmune diseases, transplant rejection and rheumatoid arthritis with a quinazoline 4-substituted by a methylenedioxyphenyl group linked to the ring by an ether, methyl, sulfide, sulfoxide or sulfone, e.g., 6-methoxy-4-(2,3-methylenedioxyphenoxy)-7-(3-pyrrolidin-1-ylpropoxy)quinazoline, |
| 05/29/2007 | US7223755 Such as (2S,5S)-5-benzyl-6-hydroxy-2-(2-methylpropyl)-3-morpholinone, which has calpain inhibitory activity; for treating cataract or retinal ischemic disorder |
| 05/29/2007 | US7223741 nucleic acids containing unmethylated cytosine-guanine (CpG) dinucleotides activate lymphocytes in a subject and redirect a subject's immune response from a Th2 to a Th1 |
| 05/29/2007 | US7223736 Composition for the prevention and treatment of cachexia |
| 05/29/2007 | US7223600 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination |
| 05/29/2007 | US7223593 Anticancer agents; gene coding immunomoderator cytokine protein |
| 05/29/2007 | US7223398 Population of conjugate molecules of an allergen and a polynucleotide comprising an immunostimulatory sequence; polynucleotide conjugated, or attached, to antigens |
| 05/29/2007 | US7223394 Human antibodies that bind human TNFα |
| 05/29/2007 | US7223392 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 05/29/2007 | CA2268758C Immunogenic detoxified mutant e. coli lt-a toxin |
| 05/29/2007 | CA2213989C External preparation for topical administration |
| 05/24/2007 | WO2007058960A1 Sulfamoyl benzamides as cannabinoid receptor modulators |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007058194A1 Inhibitor of cytotoxic t cell induction |
| 05/24/2007 | WO2007058190A1 Controlled drug release composition and drug releasing medical device |
| 05/24/2007 | WO2007056870A1 Methods and compositions for pharmacologically controlled targeted immunotherapy |
| 05/24/2007 | WO2007056858A1 Anti-alpha2 integrin antibodies and their uses |
| 05/24/2007 | WO2007056854A1 Method of expanding double negative t cells |
| 05/24/2007 | WO2007056812A1 A molecule and chimeric molecules thereof |
| 05/24/2007 | WO2007020479A3 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 05/24/2007 | WO2007006533A3 Indolylmaleimide derivatives |
| 05/24/2007 | WO2006077232A3 Multimeric soluble fas ligand for eliminating alloreactive t lymphocyte in allogenic harmatopoietic stem-cell transplantation transplantation |
| 05/24/2007 | WO2006042408A9 Gh secretagogues and uses thereof |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117757 Polypeptide copolymer for use in treatment of multiple sclerosis; glatiramer acetate; copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons; chromatographic separation; cleaving by acid hydrolysis or enzymetic hydrolysis; isolation by dialysis or ultrafiltration, |
| 05/24/2007 | US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 05/24/2007 | US20070117742 producing a fraction enriched in a proteinaceous molecule having N-linked glycans comprising sialyl-Lewis X, Lewis X or LacdiNac structures; cerebral ischemia or myocardial infarction; composition comprising erythropoietin molecules |
| 05/24/2007 | US20070117189 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 05/24/2007 | US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/24/2007 | US20070117160 Novel method of screening |
| 05/24/2007 | US20070117142 Regulation of novel human asparagine-hydroxylases |
| 05/24/2007 | US20070117091 Anti-candida agents for the treatment of prion diseases |
| 05/24/2007 | US20070116708 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 05/24/2007 | US20070116694 Inhibitor of interaction of granzyme b with golgin-160 |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | DE60119515T2 Probiotica für verwendung als haustierfutter Probiotics for use as petfood |
| 05/24/2007 | CA2631166A1 Salts and mixture of -9-oxoacridine-10-acetic acid with 1-alkylamino-1-desoxy-polyols, pharmaceutical compositions containing said agents and treatment methods |